Preview

Nephrology and Dialysis

Advanced search

Definition and criteria of acute kidney disease: scoping review

https://doi.org/10.28996/2618-9801-2020-1-71-83

Abstract

Introduction: the term chronic kidney disease (CKD) is widely used in scientific studies and clinical practice and has generally accepted definition and classification. Acute kidney injury (AKI) has been studied for long time, its criteria have been modified several times. The last KDIGO recommendation was approved by a majority of the international nephrological societies. In 2012, the KDIGO Work Group also proposed the term acute kidney disease and disorders (AKD), defining this condition as a structural damage or damage of kidneys function lasting less than 3 months, including at least one of the following criteria: AKI, a glomerular filtration rate (GFR) <60 ml/min/1.73 m2, a decrease in GFR by ≥35%, an increase in serum creatinine by >50%, or any kidney damage lasting less than 3 months. Subsequently, changes to the conceptual AKD model were proposed. Up to now, the AKD term has remained relatively new not only to clinicians, but also to researchers. In order to study the formation of AKD concept, we performed a scoping review. The following research question was formulated: what definitions and/or criteria of AKD are presented in the published literature? Methods: the scoping review was performed in accordance with the recommendations of the Joanna Briggs Institute (2015) and Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR). The search of English-language publications was made by using the PubMed search engine, Russian-language publications were found in the scientific electronic library eLIBRARY.RU. Manual search was performed to find additional publications. The following search queries were formulated: “acute kidney diseas*” (with an asterisk (*) at the end of the string) and “острая болезнь почек”. Screening of publication titles and their summaries was performed in the EPPI-Reviewer 4 Software. Results: 45 articles were included in this scoping review from 443 previously identified publications. The definition and criteria of AKD, first developed by KDIGO, were used in almost half of the literary sources. Authors indicated the definition recommended by the ADQI working group in 2016 in 14 articles. There were used authors’ definitions and criteria of AKD in 11 publications, which in varying degrees differed from the proposed by KDIGO and ADQI. Conclusion: the scoping review demonstrates the lack of a unified conceptual model and a generally accepted definition of AKD. The Review results can be used to raise awareness and continue discussions on this topic in order to obtain consensus.

About the Authors

E. N. Kulakova
Department of Hospital and Polyclinic Pediatrics, N.N. Burdenko Voronezh State Medical University
Russian Federation


T. L. Nastausheva
Department of Hospital and Polyclinic Pediatrics, N.N. Burdenko Voronezh State Medical University
Russian Federation


I. V. Kondratjeva
Department of Hospital and Polyclinic Pediatrics, N.N. Burdenko Voronezh State Medical University
Russian Federation


References

1. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification and Stratification. Am J Kidney Dis39:S1-S266, 2002 (suppl 1).

2. Eknoyan G. A decade after the KDOQI CKD guidelines: a historical perspective. Am J Kidney Dis. 2012;60(5):686-688. DOI:10.1053/j.ajkd.2012.08.022

3. Eknoyan G. Chronic kidney disease definition and classification: the quest for refinements. Kidney Int. 2007;72(10):1183-1185. doi:10.1038/sj.ki.5002576

4. Kasiske B.L., Wheeler D.C. Kidney Disease: Improving Global Outcomes - An update. Nephrol Dial Transplant. 2014;29(4):763-769. doi:10.1093/ndt/gft441

5. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney inter., Suppl. 2013;3(1):1-150. doi:10.1038/kisup.2012.76

6. Thomas M.E., Blaine C., Dawnay A., et al. The definition of acute kidney injury and its use in practice. Kidney Int. 2015;87(1):62-73. doi:10.1038/ki.2014.328

7. Makris K., Spanou L. Acute Kidney Injury: Definition, Pathophysiology and Clinical Phenotypes. Clin Biochem Rev. 2016;37(2):85-98. http://www.ncbi.nlm.nih.gov/pubmed/28303073. Accessed August 10, 2019.

8. Bellomo R., Ronco C., Kellum J.A., Mehta R.L., Palevsky P., Acute Dialysis Quality Initiative workgroup. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8(4):R204-12. doi:10.1186/cc2872

9. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Inter., Suppl. 2012; 2: 1-138. doi:10.1038/kisup.2012.1

10. Mehta R.L., Kellum J.A., Shah S.V., et al. Acute kidney injury network: Report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11(2):R31. doi:10.1186/cc5713

11. Akcan-Arikan A., Zappitelli M., Loftis L.L., Washburn K.K., Jefferson L.S., Goldstein S.L. Modified RIFLE criteria in critically ill children with acute kidney injury. Kidney Int. 2007;71(10):1028-1035. doi:10.1038/sj.ki.5002231

12. Peters M.D.J., Godfrey C.M., Khalil H., McInerney P., Parker D., Soares C.B. Guidance for conducting systematic scoping reviews. Int J Evid Based Healthc. 2015;13(3):141-146. doi:10.1097/XEB.0000000000000050

13. Tricco A.C., Lillie E., Zarin W., et al. PRISMA extension for scoping reviews (PRISMA-ScR): Checklist and explanation. Ann Intern Med. 2018;169(7):467-473. doi:10.7326/M18-0850

14. James M., Bouchard J., Ho J., et al. Canadian society of nephrology commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury. Am J Kidney Dis. 2013;61(5):673-685. doi:10.1053/j.ajkd.2013.02.350

15. Levey A.S., Levin A., Kellum J.A. Definition and classification of kidney diseases. Am J Kidney Dis. 2013;61(5):686-688. doi:10.1053/j.ajkd.2013.03.003

16. Palevsky P.M., Liu K.D., Brophy P.D., et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury. Am J Kidney Dis. 2013;61(5):649-672. doi:10.1053/j.ajkd.2013.02.349

17. Chu R., Li C., Wang S., Zou W., Liu G., Yang L. Assessment of KDIGO definitions in patients with histopathologic evidence of acute renal disease. Clin J Am Soc Nephrol. 2014;9(7):1175-1182. doi:10.2215/CJN.06150613

18. Смирнов А.В., Каюков И.Г., Добронравов В.А. и соавт. Острое повреждение почек: концептуальные проблемы. Нефрология. 2014; 18(2): 8-24.

19. Levey A.S., Becker C., Inker L.A. Glomerular filtration rate and albuminuria for detection and staging of acute and chronic kidney disease in adults: A systematic review. JAMA - J Am Med Assoc. 2015;313(8):837-846. doi:10.1001/jama.2015.0602

20. Mehta R.L., Awdishu L., Davenport A., et al. Phenotype standardization for drug-induced kidney disease. Kidney Int. 2015;88(2):226-234. doi:10.1038/ki.2015.115

21. Смирнов А.В., Румянцев А.Ш., Добронравов В.А. и соавт. XXI век - время интегративной нефрологии. Нефрология. 2015; 19(2): 22-26.

22. Barry R., James M.T. Guidelines for classification of acute kidney diseases and disorders. Nephron. 2016;131(4):221-226. doi:10.1159/000441425

23. Chen S., Tang Z., Xiang H., et al. Etiology and outcome of crescentic glomerulonephritis from a single center in China: A 10-year review. Am J Kidney Dis. 2016;67(3):376-383. doi:10.1053/j.ajkd.2015.07.034

24. Kellum J.A., Ronco C., Bellomo R. Acute kidney disease and the community. Lancet. 2016;387(10032):1974-1976. doi:10.1016/S0140-6736(16)30239-2

25. Смирнов А.В., Добронравов В.А., Румянцев А.Ш., и соавт. (Рабочая группа членов Ассоциации нефрологов России) Национальные рекомендации. Острое повреждение почек: Основные принципы диагностики, профилактики и терапии. Часть 1. Нефрология. 2016; 20(1): 79-104.

26. Chawla L.S., Bellomo R., Bihorac A., et al. Acute kidney disease and renal recovery: Consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup. Nat Rev Nephrol. 2017;13(4):241-257. doi:10.1038/nrneph.2017.2

27. Forni L.G., Darmon M., Ostermann M., et al. Renal recovery after acute kidney injury. Intensive Care Med. 2017;43(6):855-866. doi:10.1007/s00134-017-4809-x

28. Göcze I., Wiesner C., Schlitt H.J., Bergler T. Renal recovery. Best Pract Res Clin Anaesthesiol. 2017;31(3):403-414. doi:10.1016/j.bpa.2017.08.006

29. Hayes W. Stop adding insult to injury-identifying and managing risk factors for the progression of acute kidney injury in children. Pediatr Nephrol. 2017;32(12):2235-2243. doi:10.1007/s00467-017-3598-3

30. Hoste E.A.J., Vandenberghe W. Epidemiology of cardiac surgery-associated acute kidney injury. Best Pract Res Clin Anaesthesiol. 2017;31(3):299-303. doi:10.1016/j.bpa.2017.11.001

31. Jiang E.X., Gogineni H.C., Mayerson J.L., Glassman A.H., Magnussen R.A., Scharschmidt T.J. Acute Kidney Disease After Total Hip and Knee Arthroplasty: Incidence and Associated Factors. J Arthroplasty. 2017;32(8):2381-2385. doi:10.1016/j.arth.2017.03.009

32. Kane-Gill S.L., Bauer S.R. AKD-the time between AKI and CKD: What is the role of the pharmacist? Hosp Pharm. 2017;52(10):663-665. doi:10.1177/0018578717733561

33. Calice-Silva V., Sacomboio E., Raimann J.G., et al. Diagnostic performance of salivary urea nitrogen dipstick to detect and monitor acute kidney disease in patients with malaria. Malar J. 2018;17(1):477. doi:10.1186/s12936-018-2627-4

34. Evans R.D.R., Cooke W., Hemmila U., et al. A Salivary Urea Nitrogen Dipstick to Detect Obstetric-Related Acute Kidney Disease in Malawi. Kidney Int Reports. 2018;3(1):178-184. doi:10.1016/j.ekir.2017.10.002

35. Evans R.D.R., Docherty M., Seeley A., et al. Incidence, etiology, and outcomes of community-acquired acute kidney injury in pediatric admissions in Malawi. Perit Dial Int. 2018;38(6):405-412. doi:10.3747/pdi.2017.00253

36. Fernandez-Juarez G., Perez J.V., Caravaca-Fontán F., et al. Duration of Treatment with Corticosteroids and Recovery of Kidney Function in Acute Interstitial Nephritis. Clin J Am Soc Nephrol. 2018;13(12):1851-1858. doi:10.2215/cjn.01390118

37. Ghasemi F., Salehi M., Khoshnam Rad N., Khalili H. Tenofovir-Associated Acute Kidney Disease. Am J Ther. September 2018:1. doi:10.1097/mjt.0000000000000847

38. Ito J., Kita H., Fujisawa T. Significance of early detection of acute kidney function worsening among outpatients having CKD using automatic calculation system for the rate of eGFR decline. Clin Exp Nephrol. 2018;22(4):898-905. doi:10.1007/s10157-018-1541-y

39. Lin Y.F., Lin S.L., Huang T.M., et al. New-onset diabetes after acute kidney injury requiring dialysis. Diabetes Care. 2018;41(10):2105-2110. doi:10.2337/dc17-2409

40. McIlroy D.R., Bellomo R., Billings F.T., et al. Systematic review and consensus definitions for the Standardised Endpoints in Perioperative Medicine (StEP) initiative: renal endpoints. Br J Anaesth. 2018;121(5):1013-1024. doi:10.1016/j.bja.2018.08.010

41. Mizuguchi K.A., Huang C.C., Shempp I., Wang J., Shekar P., Frendl G. Predicting kidney disease progression in patients with acute kidney injury after cardiac surgery. J Thorac Cardiovasc Surg. 2018;155(6):2455-2463.e5. doi:10.1016/j.jtcvs.2018.01.093

42. Moledina D.G., Luciano R.L., Kukova L., et al. Kidney biopsy-related complications in hospitalized patients with acute kidney disease. Clin J Am Soc Nephrol. 2018;13(11):1633-1640. doi:10.2215/CJN.04910418

43. Ostermann M., Chawla L.S., Forni L.G., et al. Drug management in acute kidney disease - Report of the Acute Disease Quality Initiative XVI meeting. Br J Clin Pharmacol. 2018;84(2):396-403. doi:10.1111/bcp.13449

44. Palant C.E., Patel S.S., Chawla L.S. Acute Kidney Injury Recovery. Contrib Nephrol. 2018;193:35-44. doi:10.1159/000484961

45. Rangaswamy D., Sud K. Acute kidney injury and disease: Long-term consequences and management. Nephrology. 2018;23(11):969-980. doi:10.1111/nep.13408

46. Rimes-Stigare C., Ravn B., Awad A., et al. Creatinine- and Cystatin C-Based Incidence of Chronic Kidney Disease and Acute Kidney Disease in AKI Survivors. Crit Care Res Pract. 2018;2018:7698090. doi:10.1155/2018/7698090

47. Wu C.H., Chang H.M., Wang C.Y., et al. Long-Term Outcomes in Patients with Incident Chronic Obstructive Pulmonary Disease after Acute Kidney Injury: A Competing-Risk Analysis of a Nationwide Cohort. J Clin Med. 2018;7(9):237. doi:10.3390/jcm7090237

48. Wu K.T., Chen C.Y., Chen B., Wang J.W., Lin P.C., Yen S.H. The incidence and risk factors of acute kidney disease after total knee arthroplasty with early postoperative volume supplement. Biomed Res Int. 2018;2018:8718545. doi:10.1155/2018/8718545

49. Полушин Ю.С., Соколов Д.В. Нарушение почечной функции у пациентов в критическом состоянии. Вестник анестезиологии и реаниматологии. 2018; 15 (5): 54-64. DOI: 10.21292/2078-5658-2018-15-5-54-64

50. Семидоцкая Ж.Д., Чернякова И.А., Авдеева Е.В. Схiдноєвропейський журнал внутрiшньої та сiмейної медицини. 2018; 1: 72-77. doi:10.15407/internalmed2018.01.072

51. Шаленкова М.А., Михайлова З.Д., Климкин П.Ф. NGAL - маркер субклинического острого повреждения почек у больных острым коронарным синдромом. Нефрология. 2018; 2: 43-49. doi:10.18565/nephrology.2018.2.43-49

52. James M.T., Levey A.S., Tonelli M., et al. Incidence and Prognosis of Acute Kidney Diseases and Disorders Using an Integrated Approach to Laboratory Measurements in a Universal Health Care System. JAMA Netw open. 2019;2(4):e191795. doi:10.1001/jamanetworkopen.2019.1795

53. Kofman N., Margolis G., Gal-Oz A., et al. Long-term renal outcomes and mortality following renal injury among myocardial infarction patients treated by primary percutaneous intervention. Coron Artery Dis. 2019;30(2):87-92. doi:10.1097/MCA.0000000000000678

54. Lim C.T.S., Nordin N.Z., Fadhlina N.Z., et al. Rapid decline of renal function in patients with type 2 diabetes with heavy proteinuria: A report of three cases. BMC Nephrol. 2019;20(1):22. doi:10.1186/s12882-019-1203-7

55. Lin Y.F., Chen L., Lin S.L., et al. Potential target-organ protection of mineralocorticoid receptor antagonist in acute kidney disease. J Hypertens. 2019;37(1):125-134. doi:10.1097/HJH.0000000000001876

56. Macedo E., Mehta R.L. Does acute kidney disease following primary percutaneous coronary intervention lead to chronic kidney disease development and progression? Coron Artery Dis. 2019;30(2):93-94. doi:10.1097/MCA.0000000000000713

57. Mima A., Tansho K., Nagahara D., Tsubaki K. Incidence of acute kidney disease after receiving hematopoietic stem cell transplantation: a single-center retrospective study. PeerJ. 2019;7:e6467. doi:10.7717/peerj.6467

58. Moledina D.G., Wilson F.P., Pober J.S., et al. Urine TNF-α and IL-9 for clinical diagnosis of acute interstitial nephritis. JCI Insight. 2019;4(10):e127456. doi:10.1172/jci.insight.127456

59. Писарюк А.С. Спектр нефропатий, ассоциированных с инфекционным эндокардитом: распространенность, предикторы, прогностическое значение, калькулятор риска. Дисс. на соискание уч. степени канд. мед. наук. 2018. М. 124 с.


Review

For citations:


Kulakova E.N., Nastausheva T.L., Kondratjeva I.V. Definition and criteria of acute kidney disease: scoping review. Nephrology and Dialysis. 2020;22(1):71-83. (In Russ.) https://doi.org/10.28996/2618-9801-2020-1-71-83

Views: 96


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1680-4422 (Print)
ISSN 2618-9801 (Online)